{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:14:23Z","timestamp":1793884463565,"version":"4.7.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016809","name":"Bureau of Science & Technology Nanchong City","doi-asserted-by":"crossref","award":["22JCYJPT0007"],"award-info":[{"award-number":["22JCYJPT0007"]}],"id":[{"id":"10.13039\/100016809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Clinical Specialty in Sichuan Province","award":["ZX-2428-1"],"award-info":[{"award-number":["ZX-2428-1"]}]},{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial administration of Traditional Chinese Medicine","doi-asserted-by":"crossref","award":["2024MS611"],"award-info":[{"award-number":["2024MS611"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-07-3"],"award-info":[{"award-number":["320.6750.2024-07-3"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04178-2","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:13:54Z","timestamp":1766747634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic significance of lymph node ratio in adenocarcinoma of the esophagogastric junction: a study of patients after radical gastrectomy"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiangzhi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"5","key":"4178_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Reviews Clin Oncol. 2023;20(5):338\u201349.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"4178_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13045-021-01213-z","volume":"14","author":"L Lin","year":"2021","unstructured":"Lin L, Li Z, Yan L, Liu Y, Yang H, Li H. Global, regional, and National cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019. J Hematol Oncol. 2021;14(1):197.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"4178_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"5","key":"4178_CR4","first-page":"948","volume":"23","author":"E Treppiedi","year":"2020","unstructured":"Treppiedi E, Giacopuzzi S, de Pascale S. Adenocarcinoma of the esophagogastric junction; going up or down? Gastric cancer: official. J Int Gastric Cancer Association Japanese Gastric Cancer Association. 2020;23(5):948\u20139.","journal-title":"J Int Gastric Cancer Association Japanese Gastric Cancer Association"},{"issue":"3","key":"4178_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.suc.2020.02.003","volume":"100","author":"S Kurtom","year":"2020","unstructured":"Kurtom S, Kaplan BJ. Esophagus and Gastrointestinal junction tumors. Surg Clin North Am. 2020;100(3):507\u201321.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"4178_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/nyas.13954","volume":"1434","author":"M Chevallay","year":"2018","unstructured":"Chevallay M, Bollschweiler E, Chandramohan SM, Schmidt T, Koch O, Demanzoni G, et al. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci. 2018;1434(1):132\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"34","key":"4178_CR7","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1097\/MD.0000000000001386","volume":"94","author":"K Liu","year":"2015","unstructured":"Liu K, Zhang W, Chen X, Chen X, Yang K, Zhang B, et al. Comparison on clinicopathological features and prognosis between esophagogastric junctional adenocarcinoma (Siewert II\/III Types) and distal gastric adenocarcinoma: retrospective cohort Study, a single Institution, high volume experience in China. Med (Baltim). 2015;94(34):e1386.","journal-title":"Med (Baltim)"},{"key":"4178_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12885-015-1021-7","volume":"15","author":"HH Li-Chang","year":"2015","unstructured":"Li-Chang HH, Kasaian K, Ng Y, Lum A, Kong E, Lim H, et al. Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas. BMC Cancer. 2015;15:32.","journal-title":"BMC Cancer"},{"issue":"3","key":"4178_CR9","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.21037\/jtd.2017.03.39","volume":"9","author":"CL Donohoe","year":"2017","unstructured":"Donohoe CL, Phillips AW. Cancer of the esophagus and esophagogastric junction: an 8(th) edition staging primer. J Thorac Disease. 2017;9(3):E282\u20134.","journal-title":"J Thorac Disease"},{"issue":"1","key":"4178_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/nyas.14454","volume":"1482","author":"MK Jung","year":"2020","unstructured":"Jung MK, Schmidt T, Chon SH, Chevallay M, Berlth F, Akiyama J, et al. Current surgical treatment standards for esophageal and esophagogastric junction cancer. Ann N Y Acad Sci. 2020;1482(1):77\u201384.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4178_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"Cancer J Clin"},{"issue":"4","key":"4178_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.soc.2006.07.015","volume":"15","author":"M Feith","year":"2006","unstructured":"Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am. 2006;15(4):751\u201364.","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"4178_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jtcvs.2007.03.034","volume":"134","author":"C Pedrazzani","year":"2007","unstructured":"Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg. 2007;134(2):378\u201385.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"19","key":"4178_CR14","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.7150\/jca.26351","volume":"9","author":"MZ Qiu","year":"2018","unstructured":"Qiu MZ, Wang ZX, Zhou YX, Yang DJ, Wang FH, Xu RH. Proposal for a new TNM stage based on the 7(th) and 8(th) American joint committee on cancer pTNM staging classification for gastric cancer. J Cancer. 2018;9(19):3570\u20136.","journal-title":"J Cancer"},{"issue":"7","key":"4178_CR15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/jso.25411","volume":"119","author":"A Agnes","year":"2019","unstructured":"Agnes A, Biondi A, Cananzi FM, Rausei S, Reddavid R, Laterza V, et al. Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study. J Surg Oncol. 2019;119(7):948\u201357.","journal-title":"J Surg Oncol"},{"issue":"3","key":"4178_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4048\/jbc.2018.21.e35","volume":"21","author":"M Hung","year":"2018","unstructured":"Hung M, Xu J, Nielson D, Bounsanga J, Gu Y, Hansen AR, et al. Evaluating the prediction of breast cancer survival using lymph node ratio. J Breast Cancer. 2018;21(3):315\u201320.","journal-title":"J Breast Cancer"},{"key":"4178_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fonc.2018.00628","volume":"8","author":"CH Zhang","year":"2018","unstructured":"Zhang CH, Li YY, Zhang QW, Biondi A, Fico V, Persiani R, et al. The prognostic impact of the metastatic lymph nodes ratio in colorectal cancer. Front Oncol. 2018;8:628.","journal-title":"Front Oncol"},{"issue":"1","key":"4178_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12885-023-10689-6","volume":"23","author":"H Kamiya","year":"2023","unstructured":"Kamiya H, Komatsu S, Nishibeppu K, Ohashi T, Konishi H, Shiozaki A, et al. Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction. BMC Cancer. 2023;23(1):218.","journal-title":"BMC Cancer"},{"issue":"3","key":"4178_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12029-020-00468-y","volume":"52","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu D, Zeng D, Chen C. Lymph node ratio is an independent prognostic factor for patients with Siewert type II adenocarcinoma of esophagogastric junction: results from a 10-Year Follow-up study. J Gastrointest Cancer. 2021;52(3):983\u201392.","journal-title":"J Gastrointest Cancer"},{"issue":"5","key":"4178_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ejso.2021.11.133","volume":"48","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zheng J, Li Y. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with \u2264\u200915 retrieved lymph nodes. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2022;48(5):1017\u201324.","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"3","key":"4178_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.amjsurg.2014.12.042","volume":"210","author":"M Melis","year":"2015","unstructured":"Melis M, Masi A, Pinna A, Cohen S, Hatzaras I, Berman R, et al. Does lymph node ratio affect prognosis in gastroesophageal cancer? Am J Surg. 2015;210(3):443\u201350.","journal-title":"Am J Surg"},{"issue":"7","key":"4178_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00423-013-1101-6","volume":"398","author":"L Sisic","year":"2013","unstructured":"Sisic L, Blank S, Weichert W, J\u00e4ger D, Springfeld C, Hochreiter M, et al. Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG). Langenbeck\u2019s Archives Surg. 2013;398(7):973\u201381.","journal-title":"Langenbeck\u2019s Archives Surg"},{"issue":"1","key":"4178_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/SLA.0000000000003499","volume":"274","author":"Y Kurokawa","year":"2021","unstructured":"Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, et al. Mapping of lymph node metastasis from esophagogastric junction tumors: A prospective nationwide multicenter study. Ann Surg. 2021;274(1):120\u20137.","journal-title":"Ann Surg"},{"key":"4178_CR24","doi-asserted-by":"crossref","unstructured":"Japanese Classification of Esophageal Cancer, 11th Edition: part I. Esophagus: official journal of the Japan Esophageal Society. 2017;14(1):1\u201336.","DOI":"10.1007\/s10388-016-0551-7"},{"key":"4178_CR25","doi-asserted-by":"crossref","unstructured":"Japanese classification of gastric carcinoma. 3rd English edition. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2011;14(2):101\u2009\u2013\u200912.","DOI":"10.1007\/s10120-011-0041-5"},{"key":"4178_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijsu.2019.11.002","volume":"72","author":"R Agha","year":"2019","unstructured":"Agha R, Abdall-Razak A, Crossley E, Dowlut N, Iosifidis C, Mathew G. STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery. Int J Surg (London England). 2019;72:156\u201365.","journal-title":"Int J Surg (London England)"},{"issue":"21","key":"4178_CR27","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Research: Official J Am Association Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"18","key":"4178_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMc080178","volume":"358","author":"E B\u00f6lke","year":"2008","unstructured":"B\u00f6lke E, Peiper M, Budach W. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358(18):1965. author reply.","journal-title":"N Engl J Med"},{"issue":"10","key":"4178_CR29","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/annonc\/mdm269","volume":"18","author":"S Lorenzen","year":"2007","unstructured":"Lorenzen S, Hentrich M, Haberl C, Heinemann V, Schuster T, Seroneit T, et al. Split-dose docetaxel, cisplatin and leucovorin\/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Annals Oncology: Official J Eur Soc Med Oncol. 2007;18(10):1673\u20139.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"4","key":"4178_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"21","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, et al. Esophageal and esophagogastric junction Cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2023;21(4):393\u2013422.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"1","key":"4178_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61(1):92\u2013105.","journal-title":"Biometrics"},{"issue":"12","key":"4178_CR32","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1245\/s10434-017-6078-x","volume":"24","author":"H In","year":"2017","unstructured":"In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the National cancer database. Ann Surg Oncol. 2017;24(12):3683\u201391.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"4178_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/dote.12493","volume":"29","author":"TW Rice","year":"2016","unstructured":"Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, et al. Worldwide esophageal cancer collaboration: clinical staging data. Dis Esophagus: Official J Int Soc Dis Esophagus. 2016;29(7):707\u201314.","journal-title":"Dis Esophagus: Official J Int Soc Dis Esophagus"},{"issue":"4 Pt A","key":"4178_CR34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ejso.2019.12.011","volume":"46","author":"KF Karstens","year":"2020","unstructured":"Karstens KF, Ghadban T, Sawez S, Konczalla L, Woestemeier A, Bachmann K, et al. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2020;46(4 Pt A):638\u201343.","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"1","key":"4178_CR35","doi-asserted-by":"publisher","first-page":"10123","DOI":"10.1038\/s41598-017-09625-z","volume":"7","author":"J Xu","year":"2017","unstructured":"Xu J, Cao J, Wang L, Wang Z, Wang Y, Wu Y, et al. Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction. Sci Rep. 2017;7(1):10123.","journal-title":"Sci Rep"},{"issue":"45","key":"4178_CR36","doi-asserted-by":"publisher","first-page":"74337","DOI":"10.18632\/oncotarget.11188","volume":"7","author":"H Zhang","year":"2016","unstructured":"Zhang H, Shang X, Chen C, Gao Y, Xiao X, Tang P, et al. Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection. Oncotarget. 2016;7(45):74337\u201349.","journal-title":"Oncotarget"},{"issue":"7","key":"4178_CR37","doi-asserted-by":"publisher","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","volume":"17","author":"JA Ajani","year":"2019","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, et al. Esophageal and esophagogastric junction Cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2019;17(7):855\u201383.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"1","key":"4178_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.athoracsur.2023.02.053","volume":"116","author":"JC Bolger","year":"2023","unstructured":"Bolger JC, Castro PP, Marwah A, Tavakoli I, Espin-Garcia O, Darling GE, et al. Nodal Yield\u2009<\u200915 is associated with reduced survival in esophagectomy and is a quality metric. Ann Thorac Surg. 2023;116(1):130\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"4178_CR39","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/03007995.2018.1429390","volume":"34","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Xie X, Hao N, Diao D, Song Y, Xia P, et al. Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction. Curr Med Res Opin. 2018;34(6):963\u201370.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"4178_CR40","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s00432-019-02963-7","volume":"145","author":"JE Hwang","year":"2019","unstructured":"Hwang JE, Kim H, Shim HJ, Bae WK, Hwang EC, Jeong O, et al. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer. J Cancer Res Clin Oncol. 2019;145(8):2157\u201366.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"4178_CR41","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1186\/s12885-019-6433-3","volume":"19","author":"K Shin","year":"2019","unstructured":"Shin K, Park SJ, Lee J, Park CH, Song KY, Lee HH, et al. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. BMC Cancer. 2019;19(1):1232.","journal-title":"BMC Cancer"},{"issue":"12","key":"4178_CR42","first-page":"3425","volume":"276","author":"BW Lei","year":"2019","unstructured":"Lei BW, Hu JQ, Yu PC, Wang YL, Wei WJ, Zhu J, et al. Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer. European archives of oto-rhino-laryngology: official journal of the European federation of Oto-Rhino-Laryngological societies (EUFOS) : affiliated with the German society for Oto-Rhino-Laryngology -. Head Neck Surg. 2019;276(12):3425\u201334.","journal-title":"Head Neck Surg"},{"issue":"1","key":"4178_CR43","doi-asserted-by":"publisher","first-page":"13361","DOI":"10.1038\/s41598-019-50069-4","volume":"9","author":"J Lee","year":"2019","unstructured":"Lee J, Lee SG, Kim K, Yim SH, Ryu H, Lee CR, et al. Clinical value of lymph node ratio integration with the 8(th) edition of the UICC TNM classification and 2015 ATA risk stratification systems for recurrence prediction in papillary thyroid cancer. Sci Rep. 2019;9(1):13361.","journal-title":"Sci Rep"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04178-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:01Z","timestamp":1769608981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04178-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04178-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. All methods used in this study were performed in accordance with the relevant ethical guidelines and regulations of the Nanchong Central Hospital, where the investigation was carried out. Informed consent was obtained from all patients and the study protocol was approved by the local ethical committee (ID number: 2024036).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}